摘要
目的:观察复方樟柳碱治疗糖尿病缺血性视神经病变的效果。方法:41例(63眼)随机分成两组。治疗组21例(33眼)采用患眼颞浅动脉旁皮下注射、球周注射复方樟柳碱;对照组20例(30眼)采用静脉输入血管扩张剂,注射维生素B1、B12等。观察60d。结果:两组比较结果,视力、视野、电生理差异显著,复方樟柳碱疗效明显优于对照组。结论:复方樟柳碱治疗糖尿病缺血性视神经病变是一种安全、可靠的治疗手段。
AIM： To observe the curative effect of compound anisodine on diabetic ischemic potic neuropathy.
METHODS： Forty-one cases （63 eyes） were divided randomly into study group （21 cases, 33 eyes） and control group （20 cases, 30 eyes）. The study group was given compound anisodine by hypodermic injection near superficial temporal artery and retrobulbar injection. The control group received vasodilating agent by intravenous infusion and Vitamin B1 and B12 by hypodermic injection. All the cases were observed for 60 days.
RESULTS： The curative effect of the study group was better than the control group in visual acuity, visual field and electrophysiology, with significant difference.
CONCLUSION： Compound anisodine is effective and safe for treating diabetic ischemic potic neuropathy.
出处
《国际眼科杂志》
CAS
2008年第11期2339-2340,共2页
International Eye Science
